PRODUCTS

Nanoparticle

Psigryph’s Nanopect™ platform technology that can be developed to deliver a myriad of nutrients efficiently into cells. We envision developing consumer products using this technology to offer the market other products that could:

• Lower cholesterol

• Be anti-inflammatory

• Deliver vitamins

• Deliver minerals

and possibly many more specific nutrients for different customer segments.

Nanofibre

Psigryph’s nanofibres are a platform technology that can be developed to deliver a myriad of insoluble molecules efficiently into cells.  Nanofibres have demonstrated the ability to deliver anti-cancer agents such as paclitaxel and vincristine to drug-resistant cancer cells. The result is a highly efficient destruction of these difficult to treat (known as MDR) cancer cells. 

This has potentially profound implications for the treatment of cancer and perhaps other diseases.  If this characteristic can be shown to be generalizable, then there would be many companies with insoluble molecules that could benefit from this technology.

SlimLiiv™: Phytonutrient Food Powder

The first product of the company is commercialization-ready stage SlimLiiv™, a food powder that demonstrated weight control potential in three studies.  SlimLiiv™ powder further demonstrates anti-inflammatory, cholesterol-lowering and anti-cancer effects when added to the standard diet in lab trials.  This asset can be marketed in the near term in the weight loss category and can be further refined to create a family of consumer products targeted at various health categories focused on prevention.  There is strong and growing demand from consumers for safe and effective products they can purchase to take control of their health.